NVRO

1 Day 1D

5 Days 5D

1 Month 1M

6 Months 6M

YTD YTD

1 Year 1Y

5 Years 5Y

About Nevro Corp

Headquartered in Redwood City, California, Nevro is a global medical device company focused on providing innovative products that improve the quality of life of patients suffering from debilitating chronic pain. Nevro has developed and commercialized the Senza spinal cord stimulation (SCS) system, an evidence-based, non-pharmacologic neuromodulation platform for the treatment of chronic pain. HF10 therapy has demonstrated the ability to reduce or eliminate opioids in =65% of patients across six peer-reviewed clinical studies. The Senza® System, Senza II™ System, and the Senza® Omnia™ System are the only SCS systems that deliver Nevro's proprietary HF10® therapy. Senza, Senza II, Senza Omnia, HF10, Nevro and the Nevro logo are trademarks of Nevro Corp.
CEO
D.Keith Grossman
Employees
843
Headquarters

1800 Bridge Pkwy
Redwood City, California 94065-1164
Phone: 16502510005
www.nevro.com

News

Nevro to Report Second-Quarter 2024 Financial Results and Host Earnings Conference Call on August 6, 2024
Jul 09, 2024 20:15pm

REDWOOD CITY, Calif., July 9, 2024 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company delivering comprehensive, life-changing solutions for the treatment of chronic pain, today announced that it will release its financial results for the second quarter of 2024 after…


Source:PR Newswire
Sacral Nerve Stimulation Market Set to Witness Significant Growth by 2024-2031 | Medtronic plc., Nevro Corp, Axonics,Inc
May 24, 2024 10:23am

BURLINGAME, CALIFORNIA, UNITED STATES, May 24, 2024 /⁨EINPresswire.com⁩/ -- Market Overview: Sacral nerve stimulation is a technique that uses mild electrical pulses to stimulate the sacral nerve and restore control of the bladder and bowels. It …


Source:EIN News Lung Cancer
Citi upgrades Edwards, Tandem; cuts Nevro, Establishment Labs
May 22, 2024 17:55pm

No summary available.


Source:Seeking Alpha